Graphic to begin with EPR showing selection to desired tissues (within Chapter 3), morphing into body screen shot with applications (within Chapter 2, titled “Nanocell Flexibility”).

Nanopharmaceutical Therapeutic Applications

Due to their size, nanopharmaceuticals can optimally target any disease or disorder that has new blood vessel formation (angiogenesis), including; oncology, autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease; and cardiovascular diseases including restenosis and atherosclerosis.